ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Cardiovascular Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1546176
Global, regional, and national burden of cardiovascular disease attributable to High body mass index from 1990 to 2021 and projection to 2045
Provisionally accepted
- 1GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China
- 2Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Region, China
- 3Guangxi Medical University, Nanning, Guangxi Zhuang Region, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background High body mass index (HBMI) is strongly associated with cardiovascular disease (CVD), but the global burden of CVD attributable to HBMI remains poorly defined. This study aims to elucidate the current burden and temporal trends of CVD attributable to HBMI.We used data from the Global Burden of Disease Study (GBD) 2021 to estimate CVD deaths and disability-adjusted life years (DALYs) attributable to HBMI.Our analysis examines trends in deaths and DALYs by age, gender, and Sociodemographic Index (SDI) across global, regional, and national levels from 1990 to 2021.We used health inequality and decomposition analyses to quantify the influencing factors of disease burden and a Bayesian age-period-cohort (BAPC) model to predict the potential trend of HBMI on CVD burden.In 2021, HBMI-related CVD resulted in approximately 1.9 million deaths and 45.43 million DALYs among urban and rural populations, with an age-standardized mortality rate (ASMR) of 22.77 (95% UI, 12.87-34.24) and an age-standardized disability rate (ASDR) of 529.00 (95% UI, 277.28-808.64) per 100,000 people. Over the study period, the overall CVD burden attributable to HBMI decreased significantly, while the burden of atrial fibrillation and flutter increased. The disease burden was closely tied to socioeconomic development and was unevenly distributed, with middle SDI regions experiencing a heavier burden. The highest burden was observed in individuals aged 84 and older, with a significant increase in the 20-44 age group. Decomposition analysis revealed that the increase in DALYs was driven by population growth. Projections from the BAPC model suggest that by 2045, global DALYs of CVD attributable to HBMI may continue to increase.This study provides a comprehensive epidemiological assessment of the CVD burden attributable to HBMI across various regions and populations, offering valuable insights for guiding policy and research efforts.
Keywords: cardiovascular disease, high body mass index, Epidemiology, global, Public Health
Received: 16 Dec 2024; Accepted: 07 Apr 2025.
Copyright: © 2025 Li, Liang, Song and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hui Li, GMU-GIBH Joint School of Life Sciences, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, Guangzhou Medical University, Guangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.